Company: LIDRW
Filing Date: 2025-02-25
Form Type: S-1/A
Source: 0000947871-25-000219
Chunk: 2

Company: AEye, Inc.
Filing Date: 2025-02-25
Form: S-1/A
Chunk 2
---
>

This prospectus relates to the offer and resale of up to 9,638,718
shares of our common stock, par value $0.0001 per share (the “Common Stock”) by certain selling stockholders named herein
(the “Selling Stockholders”). The shares of Common Stock being offered by the Selling Stockholders have been and may be issued
pursuant to certain securities purchase agreements that we entered into with each Selling Stockholder. The shares registered for resale
include (a) 330,823 shares of Common Stock that we issued to a Selling Stockholder pursuant to the Dowslake Purchase Agreement (as defined
below) and (b) 9,307,985 shares of Common Stock issuable upon the conversion of the Convertible Note (as defined below) or exercise of
the Warrant (as defined below) issued to a Selling Stockholder. We are not selling any securities under this prospectus and will not
receive any of the proceeds from the sale of our Common Stock by the Selling Stockholders, although we will receive the exercise price
of the Warrant exercised by the Selling Stockholders for cash.

We are registering the offer and resale of the Common Stock held by the
Selling Stockholders to satisfy the registration rights granted to the Selling Stockholders in connection with each of the Transactions
(as defined below).

The Selling Stockholders may sell, transfer or otherwise
dispose of any or all of the shares of Common Stock offered by this prospectus from time to time on The Nasdaq Capital Market or any other
stock exchange, market, or trading facility on which the shares are traded, or in private transactions. Sales of the shares of Common
Stock by the Selling Stockholders may occur at fixed prices, at prevailing market prices at the time of sale, at prices related to the
prevailing market price, at varying prices determined at the time of sale, or at negotiated prices. The Selling Stockholders may sell
the shares of the Common Stock to or through underwriters, broker-dealers or agents, who may receive compensation in the form of discounts,
concessions or commissions from the Selling Stockholders, the purchasers of the shares, or both. If required, the number of shares to
be sold, the public offering price of those shares, the names of any underwriters, broker-dealers or agents and any applicable commission
or discount will be included in a supplement to this prospectus, called a prospectus supplement. See the disclosure under the heading
“Plan